Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Fulcrum Therapeutics, Inc. (FULC) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2023 8-K Quarterly results
08/22/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Corporate Presentation - FTX-6058 for Sickle Cell Disease Program Update",
"Corporate Presentation - FTX-6058 for Sickle Cell Disease Program Update"
08/03/2023 8-K Quarterly results
Docs: "Dee Smith Executive Director, Corporate Communications Fulcrum Therapeutics,"
07/10/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
06/09/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Certificate of Amendment of the Restated Certificate of Incorporation of Fulcrum Therapeutics, Inc",
"Certificate of Amendment of the Restated Certificate of Incorporation of Fulcrum Therapeutics, Inc"
05/15/2023 8-K Quarterly results
Docs: "Dee Smith Executive Director, Corporate Communications Fulcrum Therapeutics,"
04/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
03/09/2023 8-K Quarterly results
Docs: "Dee Smith Executive Director, Corporate Communications Fulcrum Therapeutics,"
01/18/2023 8-K Quarterly results
01/17/2023 8-K Quarterly results
01/04/2023 8-K Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Fulcrum Therapeutics Provides Business Update and 2023 Outlook",
"Slide from Corporate Presentation"
11/08/2022 8-K Quarterly results
Docs: "Stern Investor Relations, Inc."
10/19/2022 8-K Quarterly results
08/23/2022 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
08/16/2022 8-K Quarterly results
08/11/2022 8-K Quarterly results
08/11/2022 8-K Quarterly results
07/11/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
06/09/2022 8-K Quarterly results
06/06/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
03/10/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/03/2022 8-K Quarterly results
01/10/2022 8-K Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "Fulcrum Therapeutics ® Announces Upcoming Milestones to Support Its Mission of Treating the Root Cause of Rare Genetic Diseases"
12/06/2021 8-K Quarterly results
11/17/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Fulcrum Therapeutics ® Appoints Sonja L. Banks to its Board of Directors"
11/04/2021 8-K Quarterly results
Docs: "Fulcrum Therapeutics ® Reports Recent Business Highlights and Third Quarter 2021 Financial Results – On-track to initiate enrollment by year-end in Phase 1b clinical trial of FTX-6058 in people with sickle cell disease –"
08/12/2021 8-K Quarterly results
08/10/2021 8-K Quarterly results
06/24/2021 8-K Quarterly results
06/11/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy